Solid Biosciences Inc.
Solid Biosciences Inc.（SLDB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · SLDB · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
29
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Solid Biosciences Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
SLDB 季度内部人买卖趋势
SLDB 内幕交易卖出 · SLDB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · SLDB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
SLDB 高管卖出股份 · SLDB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 2, 2026 | SMITH IAN F Director | Option | 3,441 | — | Form 4 |
| Feb 13, 2026 | Cumbo Alexander President and CEO · Director | Option | 30,031 | — | Form 4 |
| Feb 18, 2026 | Cumbo Alexander President and CEO · Director | Sale | 16,644 | $97K | Form 4 |
| Feb 13, 2026 | Hanrahan Jessie Chief Regulatory Officer | Option | 8,125 | — | Form 4 |
| Feb 18, 2026 | Hanrahan Jessie Chief Regulatory Officer | Sale | 4,134 | $24K | Form 4 |
| Feb 13, 2026 | Ganot Ilan Director | Option | 4,861 | — | Form 4 |
| Feb 18, 2026 | Ganot Ilan Director | Sale | 2,658 | $15K | Form 4 |
| Feb 13, 2026 | Herzich Paul CTO | Option | 7,187 | — | Form 4 |
| Feb 18, 2026 | Herzich Paul CTO | Sale | 3,616 | $21K | Form 4 |
| Feb 13, 2026 | Howton David T COO | Option | 14,687 | — | Form 4 |
| Feb 18, 2026 | Howton David T COO | Sale | 7,469 | $43K | Form 4 |
| Feb 13, 2026 | Brooks Gabriel Chief Medical Officer | Option | 10,937 | — | Form 4 |
| Feb 13, 2026 | Tan Kevin CFO & Treasurer | Option | 10,625 | — | Form 4 |
| Feb 18, 2026 | Tan Kevin CFO & Treasurer | Sale | 5,404 | $31K | Form 4 |
| Feb 4, 2026 | Howton David T COO | Sale | 18,894 | $122K | Form 4 |
| Feb 4, 2026 | Cumbo Alexander President and CEO · Director | Sale | 48,913 | $315K | Form 4 |
| Feb 4, 2026 | Ganot Ilan Director | Sale | 7,205 | $46K | Form 4 |
| Feb 4, 2026 | Tan Kevin CFO & Treasurer | Sale | 14,783 | $95K | Form 4 |
| Feb 4, 2026 | Brooks Gabriel Chief Medical Officer | Sale | 12,616 | $81K | Form 4 |
| Feb 4, 2026 | Hanrahan Jessie Chief Regulatory Officer | Sale | 12,348 | $80K | Form 4 |
| Feb 4, 2026 | Herzich Paul CTO | Sale | 10,905 | $70K | Form 4 |
| Jan 31, 2026 | Tan Kevin CFO & Treasurer | Option | 33,075 | — | Form 4 |
| Feb 2, 2026 | Tan Kevin CFO & Treasurer | Sale | 26,837 | $173K | Form 4 |
| Jan 29, 2026 | Tan Kevin CFO & Treasurer | Option | 56,646 | — | Form 4 |
| Jan 31, 2026 | Cumbo Alexander President and CEO · Director | Option | 100,400 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 SLDB 内幕交易
SLDB 内幕交易
Solid Biosciences Inc.（SLDB）内幕交易数据来源于公司内部人（包括Ganot Ilan (Director), Howton David T (COO), Tan Kevin (CFO & Treasurer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。SLDB内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Solid Biosciences Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
SLDB 内幕交易 · 5个问题Solid Biosciences Inc.（SLDB）的内部人包括高管和董事，如Ganot Ilan (Director), Howton David T (COO), Tan Kevin (CFO & Treasurer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026